Is it better to use an ACE inhibitor, angiotensin receptor blocker (ARB), or both in patients at risk for heart disease?

Is it better to use an ACE inhibitor, angiotensin receptor blocker (ARB), or both in patients at risk for heart disease?

This debate has been going on for years.

Now new evidence will help quell the controversy.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote